Endometrial intraepithelial neoplasia

Arch Pathol Lab Med. 2014 Apr;138(4):484-91. doi: 10.5858/arpa.2012-0709-RA.

Abstract

Context: Developed in conjunction with molecular and progression data, the sequence classification schema for endometrial intraepithelial neoplasia (EIN)/benign hyperplasia (BH) provides an easy to adopt and reproducible method for classification of endometrial biopsies.

Objective: To review current data supporting the use of BH/EIN to classify endometrial biopsies, and to discuss the hormone-driven endometrial sequence from anovulation/disordered proliferative endometrium through BH and EIN and their diagnostic difficulty.

Data sources: A comprehensive review of EIN literature based on literature indexed by PubMed (National Library of Medicine) and Google Scholar.

Conclusions: The BH/EIN schema is gaining wider acceptance among pathologist and clinicians. The research leading to the EIN criteria is based on molecular and progression data. The BH/EIN schema has better reproducibility among pathologists, is intuitively easy to use, and requires understanding of endometrial physiology and neoplasia.

Publication types

  • Review

MeSH terms

  • Carcinoma in Situ / diagnosis*
  • Carcinoma in Situ / genetics
  • Carcinoma in Situ / pathology
  • Diagnosis, Differential
  • Endometrial Hyperplasia / diagnosis*
  • Endometrial Hyperplasia / genetics
  • Endometrial Hyperplasia / pathology
  • Endometrial Neoplasms / diagnosis*
  • Endometrial Neoplasms / genetics
  • Endometrial Neoplasms / pathology
  • Endometrium / pathology
  • Female
  • Humans
  • Metaplasia
  • Mutation
  • PAX2 Transcription Factor / genetics
  • PTEN Phosphohydrolase / genetics

Substances

  • PAX2 Transcription Factor
  • PAX2 protein, human
  • PTEN Phosphohydrolase
  • PTEN protein, human